ACRS: Aclaris Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Aclaris Therapeutics (ACRS) kompaniyasida kichik molekulali klinik sinovlarga bog'liqlik bilan bog'liq xatarlar kapitalni mustahkamlovchi daromadli litsenziyalash shartnomalari bilan yo'q qilinadi. Joriy PEG koeffitsiyenti bozor baholashini aks ettiradi, bunda parametr 0.00 darajasida barqarorlashgan. Biznes barqarorligi teri patologiyalari uchun terapiyalarni ishlab chiqish maqsadida immunologiya markazlari bilan tuzilgan ilmiy ittifoqlar orqali yanada qo'llab-quvvatlanmoqda.
Aclaris (ACRS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Aclaris Therapeutics|ACRS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Aclaris Therapeutics, Inc.|ACRS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Aclaris Therapeutics, Inc|ACRS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Aclaris Therapeutics|Tezkor likvidlik ko‘rsatkichi aclaristx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ACRS - Kompaniyaning sof foydasi|Kutilayotgan foyda Aclaris Therapeutics|ACRS - P/E multiplikatori|Forvard P/E multiplikatori aclaristx.com|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Aclaris Therapeutics, Inc|ACRS - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Aclaris Therapeutics|ACRS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi aclaristx.com|ACRS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Aclaris Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ACRS - Aclaris
Aclaris Therapeutics kompaniyasining yallig'lanishli teri va bo'g'im patologiyalari uchun innovatsion davolash vositalarini ishlab chiqishi R&D xarajatlarining kelajakdagi daromadlar bilan aniq muvofiqlashtirilishini talab qiladi. GURU.Markets platformasida kompaniyaning narx-o'sish nisbatini tahlil qilish joriy P/E ko'rsatkichini prognoz qilingan foyda o'sishi bilan nisbatan baholash imkonini beradi, bunda birdan past qiymat aktivning qadrini past baholanganligini va yuqori kapital barqarorligiga ega ekanligini anglatadi.
Raqobatdosh kompaniyalar
ARGX (Argenx) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (biontech.de)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax S.A. (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|Protagonist Therapeutics, Inc. (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant Therapeutics (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori adaptivebiotech.com|Narxning foydaga va o‘sish sur’atiga nisbati Celldex (CLDX)|Aurinia Pharmaceuticals Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Therapeutics, Inc. - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tourmaline Corp (TRML)|PGEN (precigen.com) - PEG multiplikatori|PEG multiplikatori Pharming Corp|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Bio Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Bio ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharmaceuticals KALV|Septerna (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|pieris.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS (Astria Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Holdings Inc. ENGN|PEG multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Kyverna Therapeutics Inc.|TLSA: PEG multiplikatori|CABA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|VTYX (ventyxbio.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Theratechnologies Inc. THTX|Narx-foyda va o‘sish multiplikatori AVTX (avalotx.com)|Narx-foyda va o‘sish multiplikatori Eledon Pharmaceuticals, Inc. ELDN|Narxning foydaga va o‘sish sur’atiga nisbati Agenus, Inc AGEN|Climb Bio Inc - Narxning foydaga va o‘sish sur’atiga nisbati|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati IMA (ImageneBio)|Narx-foyda va o‘sish multiplikatori STTK|EQ: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Connect Pharma (CNTB)|PEG multiplikatori Immunic Therapeutics (IMUX)|PEG multiplikatori ATRA (Atara Biotherapeutics)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IFRX|XFOR (X4 Pharma) - O‘sish sur’atiga tuzatilgan narx-foyda|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (adicetbio.com)|CELU: PEG multiplikatori|inmunebio.com (INMB) - PEG multiplikatori|BRNS (Barinthus Biotherapeutics PLC) - PEG multiplikatori|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|geovax.com - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (Edesa Biotech Inc)|IBIO: PEG multiplikatori|Carisma Tx (CARM) - PEG multiplikatori|XTLB (XTL Biopharmaceuticals) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics, Inc.)|PEG multiplikatori Aptevo (APVO)|PEG multiplikatori AIM (aimimmuno.com)|PEG multiplikatori Aditxt Corp ADTX|GRI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Revelation Bio (REVB) - PEG multiplikatori|INDP (Indaptus Corp) - PEG multiplikatori|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori Affimed N.V. AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|tcbiopharm.com (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio Inc.) - PEG multiplikatori
